The Channel-Activating Protease CAP1/Prss8 Is Required for Placental Labyrinth Maturation

• Edith Hummler ,

  * E-mail: Edith.Hummler@unil.ch

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Aline Dousse,

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Audrey Rieder,

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Jean-Christophe Stehle,

  Affiliation University Institute of Pathology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Isabelle Rubera,

  Current address: University of Nice Sophia Antipolis, Unité CNRS 3472, Nice, France

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Maria-Chiara Osterheld,

  Affiliation University Institute of Pathology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Friedrich Beermann,

  Affiliation ISREC (Swiss Institute for Experimental Cancer Research), School of Life Sciences, EPFL (Ecole Polytechnique Fédérale de Lausanne), Lausanne, Switzerland

  ⨯
• Simona Frateschi,

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯
• Roch-Philippe Charles

  Current address: Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland

  Affiliation Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

  ⨯